Venture Valuation AG, Switzerland

Venture Valuation specializes in independent, third party assessment, valuation and monitoring of emerging high growth companies in industries such as biotechnology, med-tech, high-tech, IT and telecom. With offices in Switzerland, Germany and Canada, services are provided in the form of independent reports to entrepreneurs and investors. Venture Valuation has also created and maintains the global life sciences company database Biotechgate and the associated individual country portals. Through Biotechgate it has access to detailed company information which, combined with their experience in the assessment of high growth companies and their interest in the promotion of industry in the EU, enables them to contribute to the KAPPA-Health initiative.

“We hope the KAPPA-Health project will address the important issue of promoting SMEs in the EU, as these companies are what drives the economy. We believe that our expertise in the assessment and evaluation of high-growth companies will be very beneficial to the project. We are excited to see this project to take off and make an impact in the development of the EU life sciences industry”

Patrik Frei, Ph.D., lic. oec., CEO

www.venturevaluation.com